FDA Certifies Novel ADHD Drug

by Savitha C Muppala on  February 26, 2007 at 8:04 PM Drug News
RSS Email Print This Page Comment
FDA Certifies Novel ADHD Drug
Washington - The FDA has permitted the use of a new drug to treat attention deficit hyperactivity disorder. The drug known as Vyvanse, is manufactured by Shire PLC.

The company hopes that patients can have a smooth transition from the older ADHD medications to Vyvanse.

The company has further confirmed that the present drug is promising because it is difficult to abuse. The effect of this drug is best realized only when it is swallowed.

Source: Medindia
SAV

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Dyslexia Signature Drug Toxicity Bullying at School - Tips For Schools ADHD Dyscalculia / Learning Disabilities Diet to control Attention Deficit Hyperactivity Disorder 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive